By Extra Extra | 04.28.2010
An investigation by Peter Aldhous and Jim Giles of NewScientist found that some of the experts used by Pfizer to lead educational forums have been "disciplined for deficiencies in patient care, while others have been reprimanded for how they conducted drug research trials."